GRPr Theranostics: current status of imaging and therapy using GRPr targeting radiopharmaceuticals

J Kurth, M Potratz, M Heuschkel… - Nuklearmedizin …, 2022 - thieme-connect.com
Addressing molecular targets, that are overexpressed by various tumor entities, using
radiolabeled molecules for a combined diagnostic and therapeutic (theranostic) approach is …
被引用次数：3 相关文章

GRPr Theranostics: Current Status of Imaging and Therapy using GRPr Targeting Radiopharmaceuticals

J Kurth, M Potratz, M Heuschkel… - Nuklearmedizin …, 2022 - thieme-connect.com
Addressing molecular targets, that are overexpressed by various tumor entities, using
radiolabeled molecules for a combined diagnostic and therapeutic (theranostic) approach is …

GRPr Theranostics: Current Status of Imaging and Therapy using GRPr Targeting Radiopharmaceuticals.

J Kurth, M Potratz, M Heuschkel, BJ Krause… - Nuklearmedizin …, 2022 - europepmc.org
Addressing molecular targets, that are overexpressed by various tumor entities, using
radiolabeled molecules for a combined diagnostic and therapeutic (theranostic) approach is …

GRPr Theranostics: Current Status of Imaging and Therapy using GRPr Targeting Radiopharmaceuticals

J Kurth, M Potratz, M Heuschkel… - Nuklearmedizin …, 2022 - pubmed.ncbi.nlm.nih.gov
Addressing molecular targets, that are overexpressed by various tumor entities, using
radiolabeled molecules for a combined diagnostic and therapeutic (theranostic) approach is …